HK1169171A1 - Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities - Google Patents

Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities

Info

Publication number
HK1169171A1
HK1169171A1 HK12109957.8A HK12109957A HK1169171A1 HK 1169171 A1 HK1169171 A1 HK 1169171A1 HK 12109957 A HK12109957 A HK 12109957A HK 1169171 A1 HK1169171 A1 HK 1169171A1
Authority
HK
Hong Kong
Prior art keywords
catalytic
determination
methods
amount
neurotoxin polypeptide
Prior art date
Application number
HK12109957.8A
Other languages
English (en)
Chinese (zh)
Inventor
Michael Pfeil
Josef Friedrich
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of HK1169171A1 publication Critical patent/HK1169171A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK12109957.8A 2009-04-27 2012-10-10 Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities HK1169171A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21465009P 2009-04-27 2009-04-27
EP09158788 2009-04-27
PCT/EP2010/055432 WO2010124998A1 (fr) 2009-04-27 2010-04-23 Moyens et procédés pour déterminer la quantité de polypeptide neurotoxine et de ses activités catalytiques et protéolytiques

Publications (1)

Publication Number Publication Date
HK1169171A1 true HK1169171A1 (en) 2013-01-18

Family

ID=41066304

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12109957.8A HK1169171A1 (en) 2009-04-27 2012-10-10 Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities

Country Status (15)

Country Link
US (2) US8663942B2 (fr)
EP (1) EP2425251B1 (fr)
JP (1) JP5689113B2 (fr)
KR (1) KR101818777B1 (fr)
CN (1) CN102414564B (fr)
AU (1) AU2010243692B2 (fr)
BR (1) BRPI1015311B1 (fr)
CA (1) CA2757637C (fr)
ES (1) ES2647243T3 (fr)
HK (1) HK1169171A1 (fr)
IL (1) IL215441A (fr)
MX (1) MX2011011045A (fr)
PT (1) PT2425251T (fr)
RU (1) RU2545783C9 (fr)
WO (1) WO2010124998A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2544060T3 (es) * 2010-08-11 2015-08-27 Merz Pharma Gmbh & Co. Kgaa Fabricación selectiva de polipéptidos de neurotoxina recombinantes
JP6156954B2 (ja) 2012-11-21 2017-07-05 イプセン バイオイノベーション リミテッド タンパク分解性にプロセシングされたポリペプチドの製造方法
JP6608357B2 (ja) * 2013-06-28 2019-11-20 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー 細胞において神経毒ポリペプチドの生物活性を決定する手段及び方法
US10634683B2 (en) 2014-11-21 2020-04-28 Merz Pharma Gmbh & Co. Kgaa Methods for the determination of the biological activities of neurotoxin polypeptides
RU2694964C2 (ru) * 2017-12-19 2019-07-19 ФЕДЕРАЛЬНОЕ АГЕНТСТВО ПО ТЕХНИЧЕСКОМУ РЕГУЛИРОВАНИЮ И МЕТРОЛОГИИ (Росстандарт) Способ измерений каталитической активности (каталитической концентрации) ферментов с использованием методов масс-спектрометрии и спектрофотометрии с предварительной идентификацией целевого аналита и определением чистоты веществ
JP7394767B2 (ja) 2018-01-12 2023-12-08 ジェンザイム・コーポレーション ポリペプチドの定量化方法
WO2020206375A1 (fr) * 2019-04-03 2020-10-08 Technical University Of Denmark Conjugués de protéine de facteur neurotrophique et modes de réalisation associés

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
DE69033457T2 (de) * 1989-08-16 2000-09-14 Chiron Corp Prohormonspaltungsplatzblockierungsantikörper
GB9411138D0 (en) * 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
DE60032367T3 (de) * 1999-08-25 2011-03-10 Allergan, Inc., Irvine Aktivierbare rekombinante neurotoxine
US6678651B2 (en) 2000-09-15 2004-01-13 Mindspeed Technologies, Inc. Short-term enhancement in CELP speech coding
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
JP5178009B2 (ja) * 2003-12-19 2013-04-10 ウィスコンシン アルムニ リサーチ ファンデイション ボツリヌス神経毒素検出のための方法および複合体
FR2869908B1 (fr) * 2004-05-05 2006-07-28 Pharmaleads Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
KR20100020972A (ko) * 2007-06-01 2010-02-23 메르츠 파마 게엠베하 운트 코. 카가아 보툴리늄 톡신의 신경독 성분에 기초한 온도-안정한 근육 이완제를 제공하는 방법
WO2008157374A1 (fr) * 2007-06-13 2008-12-24 The United States Of America, As Represented By The Secretrary Of Agriculture Anticorps monoclonaux à affinité élevée pour une toxine botulinique de type a
EP2178905B1 (fr) * 2007-07-26 2013-11-06 Allergan, Inc. Procédés d'activation de toxines clostridiales
CN101386648B (zh) * 2008-09-25 2012-05-30 中国人民解放军军事医学科学院微生物流行病研究所 抗b型肉毒神经毒素中和性单克隆抗体、其制备方法及用途
MX340772B (es) * 2009-02-19 2016-07-26 Merz Pharma Gmbh & Co Kgaa Medios y metodos para fabricar neurotoxina altamente pura.

Also Published As

Publication number Publication date
CN102414564A (zh) 2012-04-11
RU2545783C9 (ru) 2016-02-27
CA2757637C (fr) 2017-10-24
AU2010243692A1 (en) 2011-10-27
IL215441A0 (en) 2011-12-29
ES2647243T3 (es) 2017-12-20
AU2010243692B2 (en) 2015-03-05
RU2011147994A (ru) 2013-06-10
IL215441A (en) 2015-04-30
US20120142024A1 (en) 2012-06-07
MX2011011045A (es) 2011-11-04
EP2425251B1 (fr) 2017-10-25
US8663942B2 (en) 2014-03-04
PT2425251T (pt) 2017-11-27
KR20120005041A (ko) 2012-01-13
CN102414564B (zh) 2015-01-21
JP2012525563A (ja) 2012-10-22
CA2757637A1 (fr) 2010-11-04
KR101818777B1 (ko) 2018-01-15
US20140134643A1 (en) 2014-05-15
BRPI1015311B1 (pt) 2024-01-09
EP2425251A1 (fr) 2012-03-07
BRPI1015311A2 (pt) 2016-04-19
JP5689113B2 (ja) 2015-03-25
RU2545783C2 (ru) 2015-04-10
WO2010124998A1 (fr) 2010-11-04

Similar Documents

Publication Publication Date Title
HK1257876A1 (zh) 包含蛋白酶、澱粉酶、和脂酶的組合物
HK1247629A1 (zh) 用於獲得肉毒桿菌神經毒素的方法和系統
HK1169171A1 (en) Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities
HRP20180854T1 (hr) Polipeptid koji ima aktivnost beta-glukozidaze i njegova uporaba
IL244154A0 (en) Botulinum neurotoxin for use in the treatment of depression
IL208373A (en) Polypeptides modified factor fvii with increased coagulation activity and various aspects based on these polypeptides
EP2802652A4 (fr) Enzymes de clostridium histolyticum et procédés pour les utiliser
PL2588492T3 (pl) Polipeptyd mający aktywność beta-glukozydazy i jego zastosowania
SG184345A1 (en) Amphiphilic linear peptide/peptoid and hydrogel comprising the same
DK2418941T3 (da) Enzymindgivelsessystemer og fremgangsmåder til fremstilling og anvendelse
EP2593469A4 (fr) Protéines et polypeptides modifiés et leurs utilisations
IL218209A (en) Isolated peptide containing catalyzed domains of human loxl2 protein
HK1210190A1 (en) Means and methods for determination of botulinum neurotoxin biological activity
EP2496609A4 (fr) Particules de type viral (vlp) chimériques à base de gag de polypeptide rsv-f et de lentivirus ou alpharétrovirus
EP2580345A4 (fr) Procédés d'indication d'activité de protéase de règle n-terminale
IL222966A0 (en) Neuregulin isoforms, neuregulin polypeptides and uses thereof
EP2468859A4 (fr) Nouvelle protéine possédant une activité b-glucosidase et utilisation associée
IL220359A (en) Recombinant histolyticum collagenases and a method for their production
EP2638152A4 (fr) Protéines bêta-glucocérébrosidase recombinantes, variantes, ayant une stabilité accrue et une activité catalytique résiduelle accrue
PL2526200T3 (pl) Test in vitro do oznaczania ilościowego aktywności neurotoksyny klostridialnej
EP2752495A4 (fr) Procédé de détermination de l'activité d'une enzyme protéolytique (variantes), dispositif pour la mise en oeuvre de celui-ci et procédé de diagnostic
HK1146471A1 (en) Polypeptide derived from enterococcus and its use for vaccination
HK1208706A1 (en) Cellular test systems for the determination of the biological activities of neurotoxin polypeptides
GB0908949D0 (en) Novel polypeptides having endolysin activity and uses thereof
EP2582789A4 (fr) Marquage isotopique utilisable en vue de la mesure des niveaux globaux de protéines et de leur renouvellement in vivo